Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.
- DOI
- 10.1093/mr/roag066
- Published
- 2026 Aug 19
- Container
- Modern rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1093/mr/roag066,
title = {Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.},
author = {Okamoto N and Fujii T and Atsumi T and Abe A and Takahashi N and Tamura N and Nakajima A and Nakajima A and Nakayamada S and Nishida K and Matsuno H and Asamura T and Koyano M and Hayashi A and Yoshida M and Noda D and Kaneko N and Saito S and Takagi M and Tanaka S and Takeuchi T and Tanaka Y and Kuwana M},
year = {2026},
journal = {Modern rheumatology},
doi = {10.1093/mr/roag066},
url = {https://doi.org/10.1093/mr/roag066}
}RIS
TY - JOUR TI - Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study. AU - Okamoto N AU - Fujii T AU - Atsumi T AU - Abe A AU - Takahashi N AU - Tamura N AU - Nakajima A AU - Nakajima A AU - Nakayamada S AU - Nishida K AU - Matsuno H AU - Asamura T AU - Koyano M AU - Hayashi A AU - Yoshida M AU - Noda D AU - Kaneko N AU - Saito S AU - Takagi M AU - Tanaka S AU - Takeuchi T AU - Tanaka Y AU - Kuwana M PY - 2026 JO - Modern rheumatology DO - 10.1093/mr/roag066 UR - https://doi.org/10.1093/mr/roag066 ER -
APA
N, O., T, F., T, A., A, A., N, T., N, T., A, N., A, N., S, N., K, N., H, M., T, A., M, K., A, H., M, Y., D, N., N, K., S, S., M, T., S, T., T, T., Y, T., & M, K. (2026). Safety of intravenous and subcutaneous belimumab in Japanese patients with systemic lupus erythematosus: Final analysis of data from an all-case post-marketing surveillance study.. Modern rheumatology. https://doi.org/10.1093/mr/roag066
Source records
- pubmed · retrieved 2026-09-25T18:05:13.250Z